Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanesen         Patients with Advanced Colorectal Cancer

Yasutsuna Sasaki

首页> 外文期刊>Japanese Journal of Clinical Oncology >Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanesen Patients with Advanced Colorectal Cancer

【24h】

Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanesen Patients with Advanced Colorectal Cancer

机译：基于UGT1A1基因型和身体背景的一线FOLFIRI和FOLFOX方案的选择对于日本人大肠癌患者是可行的

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Japanese Journal of Clinical Oncology》 |2011年第5期|p.617-623|共7页
作者
Yasutsuna Sasaki;
展开▼
作者单位

Saitama Medical University,;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer. [J] . Ishida H, Fujita K, Akiyama Y, Japanese journal of clinical oncology. . 2011,第5期

机译：基于UGT1A1基因型和身体背景的一线FOLFIRI和FOLFOX方案的选择对日本晚期大肠癌患者是可行的。
2. The genotyping of UGT1A1 polymorphism for the dose adjustment of irinotecan in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab as the first-line regimen [J] . Chien-Yu Lu, Hsiang-Lin Tsai, Jaw-Yuan Wang Biomarkers and genomic medicine. . 2013,第3期

机译：UGT1A1基因多态性用于伊立替康剂量调整的FOLFIRI加贝伐单抗一线方案治疗转移性结直肠癌患者的剂量
3. FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping [J] . Chang S.-F., Chen C.-F., Hu H.-M., Medical principles and practice: international journal of the Kuwait University, Health Science Centre . 2014,第5期

机译：FOLFIRI联合贝伐单抗作为UGT1A1基因分型后转移性结直肠癌高胆红素血症患者的一线治疗
4. The Two First-Line Recommended Antiretroviral Regimens for Naive HIV-Infected Patients: Efavirenz-Based Versus Lopinavir-Ritonavir-Based Haart [C] . R. Manfredi, L. Calza, F. Chiodo International AIDS Conference . 2004

机译：幼稚艾滋病毒感染患者的两种第一线推荐的抗逆转录病毒方案：efavirenz为基于Lopinavir-Ritonavir的HAART
5. Evaluation of the accuracy of quantitative models in predicting Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) mutations in a population-based sample of early-onset colorectal cancer patients [D] . Carpiniello, Lauren 2007

机译：在以人群为基础的早发性大肠癌患者样本中预测定量模型预测Lynch综合征（遗传性非息肉病性大肠直肠癌，DNA失配修复缺陷）的准确性
6. FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping [O] . Yung-Sung Yeh, Meng-Lin Huang, Se-Fen Chang, 2014

机译：FOLFIRI联合贝伐单抗作为UGT1A1基因分型后转移性结直肠癌高胆红素血症患者的一线治疗
7. Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanese Patients with Advanced Colorectal Cancer [O] . H. Ishida, K.-i. Fujita, Y. Akiyama, 2011

机译：基于UGT1A1基因型和物理背景的小线对Folfiri和Folfox的方案选择是日本晚期结直肠癌的患者可行的

Regimen Selection for First-line FOLFIRI and FOLFOX Based on UGT1A1 Genotype and Physical Background is Feasible in Japanesen Patients with Advanced Colorectal Cancer

著录项

相似文献

相关主题

期刊订阅